Guizhou Yibai Pharmaceutical Co., Ltd.

¥3.20As of Sun 8 Nov 2026, 12:00 UTC
SSE:600594Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (13.94%)
Div yield —
ROE (16.97%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.31
PE TTM —
TSR TTM (23.63%)
Mkt cap ¥2.510B
ROIC (9.46%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥4.04
26.30%
(60.90%)
Hold 7|1|4|1|6
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.04
0.04
0.04
0.05
13.42%
11.14%
0.23%
6.36%
Revenue¥M
255.0
253.8
259.9
260.9
4.80%
5.37%
3.33%
5.17%
Peers (US$376.3M)
Cap (US$)
PE
372.0M
29.24x
Capital
TTM
5Y
10Y
Leveragex
2.780
0.321
0.313
EBIT/Intx
1.126
0.495
0.487
Own earn%
8.87
(64.19)
(58.11)
Sh yield%
14.48
24.69
23.50
Owners
Insiders/Inst%
11.65
74.72
Short interest%
4.65
SBC / revenue%
3.78
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
9–16
$1 testx
—
Incr. ROIC%
4